Advisory Services Network’s Rigel Pharmaceuticals RIGL Stock Holding History

Advisory Services Network’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.5K	Sell	501 -43,165	-99%	-$1.45M	﹤0.01%	3400
2025 Q4	$1.87M	Buy	43,666 +11,945	+38%	+$450K	0.03%	624
2025 Q3	$899K	Buy	+31,721	New	+$949K	0.01%	915
2024 Q1	–	Sell	-270	Closed	-$3.92K	–	3196
2023 Q4	$3.92K	Buy	+270	New	+$2.76K	﹤0.01%	3194
2023 Q2	–	Sell	-200	Closed	-$2.64K	–	3180
2023 Q1	$2.64K	Hold	200	–	–	﹤0.01%	3362
2022 Q4	$3K	Buy	+200	New	+$1.83K	﹤0.01%	3290
2021 Q3	–	Sell	-13	Closed	-$1K	–	2839
2021 Q2	$1K	Buy	+13	New	+$491	﹤0.01%	3497
2021 Q1	–	Sell	-13	Closed	–	–	2608
2020 Q4	$0	Sell	13 -20	-61%	-$579	﹤0.01%	3636
2020 Q3	$1K	Buy	+33	New	+$810	﹤0.01%	3388
2020 Q2	–	Sell	-21	Closed	–	–	2380
2020 Q1	$0	Hold	21	–	–	﹤0.01%	3246
2019 Q4	$0	Buy	+21	New	+$432	﹤0.01%	3225

Other funds holding RIGL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advisory Services Network's RIGL Position: Q1 2026 in Review

Advisory Services Network reduced its Rigel Pharmaceuticals (RIGL) stake by 99% in Q1 2026, selling an estimated $1.45M and leaving 501 shares worth $13.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3400.

Advisory Services Network first reported a position in RIGL in Q4 2019 and has held it in 11 quarters since. The position peaked at $1.87M in Q4 2025. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

Advisory Services Network held 501 shares of Rigel Pharmaceuticals worth $13.5K as of Q1 2026.
Advisory Services Network sold 43,165 Rigel Pharmaceuticals shares in Q1 2026, an estimated $1.45M.
Rigel Pharmaceuticals made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #3400 holding.
Advisory Services Network first reported a position in Rigel Pharmaceuticals in Q4 2019 and has held it in 11 quarters since.
Advisory Services Network's Rigel Pharmaceuticals position peaked at $1.87M in Q4 2025.
159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.